Your browser doesn't support javascript.
loading
Characteristics of pyrexia in BRAFV600E/K metastatic melanoma patients treated with combined dabrafenib and trametinib in a phase I/II clinical trial.
Menzies, A M; Ashworth, M T; Swann, S; Kefford, R F; Flaherty, K; Weber, J; Infante, J R; Kim, K B; Gonzalez, R; Hamid, O; Schuchter, L; Cebon, J; Sosman, J A; Little, S; Sun, P; Aktan, G; Ouellet, D; Jin, F; Long, G V; Daud, A.
Afiliação
  • Menzies AM; Melanoma Institute Australia and The University of Sydney, Sydney, Australia alexander.menzies@sydney.edu.au.
  • Ashworth MT; University of California San Francisco, San Francisco.
  • Swann S; Clinical Statistics, GlaxoSmithKline, Collegeville, USA.
  • Kefford RF; Melanoma Institute Australia and The University of Sydney, Sydney, Australia Westmead Hospital, University of Sydney, Sydney Westmead Millennium Institute, University of Sydney, Sydney, Australia.
  • Flaherty K; Massachusetts General Hospital Center, Boston.
  • Weber J; Department of Cutaneous Oncology, Moffitt Cancer Center, Tampa.
  • Infante JR; Sarah Cannon Research Institute/Tennessee Oncology, PLLC, Nashville.
  • Kim KB; California Pacific Medical Center, San Francisco.
  • Gonzalez R; Department of Medical Oncology, The University of Colorado Cancer Center, Aurora.
  • Hamid O; Department of Oncology, The Angeles Clinic and Research Institute, Santa Monica.
  • Schuchter L; Penn Medicine, The University of Pennsylvania, Philadelphia, USA.
  • Cebon J; Oncology Unit, Ludwig Institute for Cancer Research, Heidelberg, Australia.
  • Sosman JA; Department of Oncology, Vanderbilt University Medical Centre, Nashville, USA.
  • Little S; Clinical Statistics, GlaxoSmithKline, Collegeville, USA.
  • Sun P; Clinical Statistics, GlaxoSmithKline, Collegeville, USA.
  • Aktan G; Clinical Statistics, GlaxoSmithKline, Collegeville, USA.
  • Ouellet D; Clinical Statistics, GlaxoSmithKline, Collegeville, USA.
  • Jin F; Clinical Statistics, GlaxoSmithKline, Collegeville, USA.
  • Long GV; Melanoma Institute Australia and The University of Sydney, Sydney, Australia Westmead Millennium Institute, University of Sydney, Sydney, Australia.
  • Daud A; University of California San Francisco, San Francisco.
Ann Oncol ; 26(2): 415-21, 2015 Feb.
Article em En | MEDLINE | ID: mdl-25411413
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Pele Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Febre / Melanoma Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Austrália
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Pele Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Febre / Melanoma Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Austrália